Source: Annual Congress 2004 - New and emerging pharmacological strategies in the treatment of asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Kazakova, O. Vasilyeva, N. Kolganova (Moscow, Russia). Clinical improvements in patients with latex - induced asthma treated with RuzamÔ. Eur Respir J 2004; 24: Suppl. 48, 1395

Member's Comments

No comment yet.

Related content which might interest you: Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Effect of allergic sensitization on clinical course of patients with COPD in the Hokkaido COPD cohort study Source: International Congress 2014 – COPD physiopathology Year: 2014 Which patients should be treated with anti-IgE? Source: Eur Respir Rev 2007; 16: 85-87 Year: 2007 10 Year evaluation of patients with severe uncontrolled allergic asthma treated with Omalizumab. Source: International Congress 2018 – Physiological and biological insights in asthma Year: 2018 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthma Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment? Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Usefulness of induced sputum eosinophil count to assess severity and treatment outcome in asthma patients Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Effect of baseline eosinophil count on response to CYT003-QbG10 in patients with persistent allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Characteristics of asthma patients responding to anti-IgE therapy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Improvement of control and quality of life in severe allergic asthmatics patients treated with omalizumab Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II Year: 2008 Clinical characteristics of asthma patients with small airway dysfunction Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Evolution of patients with severe asthma treated with mepolizumab Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Effects of Omalizumab treatment on nasal symptoms (SNOT score) in patients treated for severe asthma. Source: International Congress 2017 – Asthma management Year: 2017 Anti-IgE: lessons from clinical trials in patients with severe allergic asthma symptomatic despite optimised therapy Source: Eur Respir Rev 2007; 16: 73-77 Year: 2007 Relationship between asthma control test (ACT) and clinical, functional and inflammatory markers in treated and non treated asthmatics Source: Annual Congress 2008 - Inflammatory biomarkers Year: 2008 Clinical characteristics and disease control of US asthma patients treated in specialty clinics Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020